Caveolae and caveolin in transmembrane signaling: Implications for human disease

被引:82
作者
Schwencke, C [1 ]
Braun-Dullaeus, RC [1 ]
Wunderlich, C [1 ]
Strasser, RH [1 ]
机构
[1] Tech Univ Dresden, Med Clin Cardiol, D-01307 Dresden, Germany
关键词
caveolae; caveolin; human disease; atherosclerosis; restenosis; malignancies;
D O I
10.1016/j.cardiores.2005.11.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The identification of various signaling molecules found within caveolae and their functional interaction with the integral membrane protein caveolin, a major structural component of caveolae, suggests that these membrane microdomains participate in transmembrane signaling. Several lines of evidence indicate that caveolin may act as a scaffolding protein by direct interaction with and modulation of the activity of multiple signaling molecules. The compartmentation of various signaling molecules in caveolae and their direct and functional interaction with caveolin provides a paradigm by which these membrane microdomains are involved in regulating signal transduction pathways. By dysregulation of these signal transduction pathways caveolins may be involved in the pathogenesis of various diseases. This review focuses on the implications as well as controversies of the contribution of caveolae and caveolins for several human diseases and the potential implications to therapeutic strategies. (c) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:42 / 49
页数:8
相关论文
共 97 条
  • [1] Bender FC, 2000, CANCER RES, V60, P5870
  • [2] Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease
    Betz, RC
    Schoser, BGH
    Kasper, D
    Ricker, K
    Ramírez, A
    Stein, V
    Torbergsen, T
    Lee, YA
    Nöthen, MM
    Wienker, TF
    Malin, JP
    Propping, P
    Reis, A
    Mortier, W
    Jentsch, TJ
    Vorgerd, M
    Kubisch, C
    [J]. NATURE GENETICS, 2001, 28 (03) : 218 - 219
  • [3] BONILLA E, 1981, AM J PATHOL, V104, P167
  • [4] Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide
    Brouet, A
    DeWever, J
    Martinive, P
    Havaux, X
    Bouzin, C
    Sonveaux, P
    Feron, O
    [J]. FASEB JOURNAL, 2004, 18 (15) : 602 - +
  • [5] Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins
    Brouet, A
    Sonveaux, P
    Dessy, C
    Moniotte, S
    Balligand, JL
    Feron, O
    [J]. CIRCULATION RESEARCH, 2001, 89 (10) : 866 - 873
  • [6] Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation
    Capozza, F
    Williams, TM
    Schubert, W
    McClain, S
    Bouzahzah, B
    Sotgia, F
    Lisanti, MP
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (06) : 2029 - 2039
  • [7] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [8] PURIFICATION AND CHARACTERIZATION OF SMOOTH-MUSCLE CELL CAVEOLAE
    CHANG, WJ
    YING, YS
    ROTHBERG, KG
    HOOPER, NM
    TURNER, AJ
    GAMBLIEL, HA
    DEGUNZBURG, J
    MUMBY, SM
    GILMAN, AG
    ANDERSON, RGW
    [J]. JOURNAL OF CELL BIOLOGY, 1994, 126 (01) : 127 - 138
  • [9] Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue
    Cohen, AW
    Razani, B
    Wang, XB
    Combs, TP
    Williams, TM
    Scherer, PE
    Lisanti, MP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 285 (01): : C222 - C235
  • [10] Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts
    Cohen, AW
    Park, DS
    Woodman, SE
    Williams, TM
    Chandra, M
    Shirani, J
    De Souza, AP
    Kitsis, RN
    Russell, RG
    Weiss, LM
    Tang, BY
    Jelicks, LA
    Factor, SM
    Shtutin, V
    Tanowitz, HB
    Lisanti, MP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (02): : C457 - C474